Header Logo

Connection

Lacey McNally to Humans

Back to Details
This is a "connection" page, showing publications Lacey McNally has written about Humans.
Lacey McNally
Connection Strength
1.110
Humans
  1. Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug; 16(4):e1983.
    View in: PubMed
    Score: 0.053
  2. Simultaneous Detection of Multiple Tumor-targeted Gold Nanoparticles in HER2-Positive Breast Tumors Using Optoacoustic Imaging. Radiol Imaging Cancer. 2023 05; 5(3):e220180.
    View in: PubMed
    Score: 0.049
  3. Advances in Imaging of Inflammation, Fibrosis, and Cancer in the Gastrointestinal Tract. Int J Mol Sci. 2022 Dec 17; 23(24).
    View in: PubMed
    Score: 0.048
  4. Multimodal Tracking of Theranostic Nanoparticles with CAR T Immunotherapy for Non-Hodgkin Lymphoma. Radiol Imaging Cancer. 2022 07; 4(4):e229015.
    View in: PubMed
    Score: 0.046
  5. Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent. Biotech Histochem. 2022 Jan; 97(1):1-10.
    View in: PubMed
    Score: 0.045
  6. Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
    View in: PubMed
    Score: 0.044
  7. Treatment and Visualization of Pancreatic Ductal Adenocarcinoma through Actively Targeted Copper 64 Nanoparticles. Radiol Imaging Cancer. 2021 03; 3(2):e219005.
    View in: PubMed
    Score: 0.043
  8. Diabetes, Obesity, and Inflammation: Impact on Clinical and Radiographic Features of Breast Cancer. Int J Mol Sci. 2021 Mar 09; 22(5).
    View in: PubMed
    Score: 0.042
  9. Development of Multispectral Optoacoustic Tomography as a Clinically Translatable Modality for Cancer Imaging. Radiol Imaging Cancer. 2020 11; 2(6):e200066.
    View in: PubMed
    Score: 0.041
  10. The neutral red assay can be used to evaluate cell viability during autophagy or in an acidic microenvironment in vitro. Biotech Histochem. 2021 May; 96(4):302-310.
    View in: PubMed
    Score: 0.041
  11. A New Approach for Automated Image Segmentation of Organs at Risk in Cervical Cancer. Radiol Imaging Cancer. 2020 03; 2(2):e204010.
    View in: PubMed
    Score: 0.040
  12. Imaging Inflammation and Infection in the Gastrointestinal Tract. Int J Mol Sci. 2019 Dec 30; 21(1).
    View in: PubMed
    Score: 0.039
  13. Osteopontin-targeted probe detects orthotopic breast cancers using optoacoustic imaging. Biotech Histochem. 2018; 93(8):608-614.
    View in: PubMed
    Score: 0.036
  14. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials. 2018 11; 182:114-126.
    View in: PubMed
    Score: 0.035
  15. Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology. Clin Cancer Res. 2016 07 15; 22(14):3432-9.
    View in: PubMed
    Score: 0.030
  16. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release. 2016 06 10; 231:60-7.
    View in: PubMed
    Score: 0.030
  17. Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. J Nanobiotechnology. 2015 Dec 01; 13:90.
    View in: PubMed
    Score: 0.029
  18. Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res. 2015 Oct 15; 21(20):4576-85.
    View in: PubMed
    Score: 0.029
  19. Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1. J Surg Res. 2015 Jan; 193(1):246-54.
    View in: PubMed
    Score: 0.027
  20. Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography. Cancer Res. 2014 Nov 01; 74(21):6271-9.
    View in: PubMed
    Score: 0.027
  21. Chloroquine-mediated cell death in metastatic pancreatic adenocarcinoma through inhibition of autophagy. JOP. 2014 Mar 10; 15(2):189-97.
    View in: PubMed
    Score: 0.026
  22. Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. J Surg Res. 2014 Jul; 190(1):111-8.
    View in: PubMed
    Score: 0.026
  23. Inhibition of autophagy with chloroquine is effective in melanoma. J Surg Res. 2013 Sep; 184(1):274-81.
    View in: PubMed
    Score: 0.025
  24. Chemoresistance in ovarian cancer linked to expression of microRNAs. Biotech Histochem. 2013 Oct; 88(7):403-9.
    View in: PubMed
    Score: 0.025
  25. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma. Ann Surg Oncol. 2013 Sep; 20(9):3059-65.
    View in: PubMed
    Score: 0.024
  26. MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells. Biotech Histochem. 2013 Oct; 88(7):397-402.
    View in: PubMed
    Score: 0.024
  27. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis. 2010 Dec; 27(8):591-600.
    View in: PubMed
    Score: 0.020
  28. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. Cancer Gene Ther. 2009 Mar; 16(3):246-55.
    View in: PubMed
    Score: 0.018
  29. 18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiol Imaging Cancer. 2025 Jan; 7(1):e240096.
    View in: PubMed
    Score: 0.014
  30. Innovative Imaging Techniques Used to Evaluate Borderline-Resectable Pancreatic Adenocarcinoma. J Surg Res. 2023 04; 284:42-53.
    View in: PubMed
    Score: 0.012
  31. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine. 2021 Mar; 65:103271.
    View in: PubMed
    Score: 0.011
  32. Analysing the nanoparticle-protein corona for potential molecular target identification. J Control Release. 2020 06 10; 322:122-136.
    View in: PubMed
    Score: 0.010
  33. Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016. Clin Breast Cancer. 2020 08; 20(4):e410-e422.
    View in: PubMed
    Score: 0.010
  34. Squaraine Dyes: Molecular Design for Different Applications and Remaining Challenges. Bioconjug Chem. 2020 02 19; 31(2):194-213.
    View in: PubMed
    Score: 0.009
  35. On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol. 2019 07; 14(7):629-635.
    View in: PubMed
    Score: 0.009
  36. Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ. 2019 10; 26(10):2100-2114.
    View in: PubMed
    Score: 0.009
  37. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death Dis. 2017 12 14; 8(12):3217.
    View in: PubMed
    Score: 0.008
  38. Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells. J Microencapsul. 2016 Jun; 33(4):391-9.
    View in: PubMed
    Score: 0.008
  39. Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer. Drug Des Devel Ther. 2014; 8:1649-58.
    View in: PubMed
    Score: 0.007
  40. Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Hum Gene Ther Clin Dev. 2014 Sep; 25(3):186-95.
    View in: PubMed
    Score: 0.007
  41. Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles. Int J Nanomedicine. 2013; 8:3603-17.
    View in: PubMed
    Score: 0.006
  42. Predictive modeling of in vivo response to gemcitabine in pancreatic cancer. PLoS Comput Biol. 2013; 9(9):e1003231.
    View in: PubMed
    Score: 0.006
  43. Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecol Oncol. 2011 Apr; 121(1):193-9.
    View in: PubMed
    Score: 0.005
  44. Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging. 2010 Apr; 9(2):59-75.
    View in: PubMed
    Score: 0.005
  45. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res. 2009 Jun 15; 15(12):4058-65.
    View in: PubMed
    Score: 0.005
  46. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 2008 Oct 15; 68(20):8369-76.
    View in: PubMed
    Score: 0.004
  47. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990 Sep; 21(9):959-73.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.